+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 3imj | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | Crystal Structure of the Grb2 SH2 Domain in Complex with a Cyclopropyl-constrained Ac-pTyr-Ile-Asn-NH2 Tripeptide Mimic | ||||||
要素 | Growth factor receptor-bound protein 2 | ||||||
キーワード | SIGNALING PROTEIN/PEPTIDE / ligand preorganization / peptide mimics / Golgi apparatus / Host-virus interaction / Phosphoprotein / SH2 domain / SH3 domain / Signaling protein-pseudopeptide ligand complex / SIGNALING PROTEIN-PEPTIDE COMPLEX | ||||||
| 機能・相同性 | 機能・相同性情報guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / Co-inhibition by BTLA / neurotrophin TRKA receptor binding / COP9 signalosome / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity ...guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / Co-inhibition by BTLA / neurotrophin TRKA receptor binding / COP9 signalosome / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants / Interleukin-15 signaling / MET activates PTPN11 / negative regulation of natural killer cell mediated cytotoxicity / MET activates RAP1 and RAC1 / vesicle membrane / Signaling by LTK / MET activates PI3K/AKT signaling / CD28 dependent Vav1 pathway / Signal regulatory protein family interactions / epidermal growth factor receptor binding / Regulation of KIT signaling / PI-3K cascade:FGFR3 / natural killer cell mediated cytotoxicity / STAT5 activation downstream of FLT3 ITD mutants / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / endodermal cell differentiation / positive regulation of actin filament polymerization / GRB2:SOS provides linkage to MAPK signaling for Integrins / RHOU GTPase cycle / regulation of MAPK cascade / RET signaling / Interleukin-3, Interleukin-5 and GM-CSF signaling / insulin receptor substrate binding / PI3K Cascade / PI3K events in ERBB2 signaling / signal transduction in response to DNA damage / SOS-mediated signalling / fibroblast growth factor receptor signaling pathway / Activated NTRK3 signals through RAS / Role of LAT2/NTAL/LAB on calcium mobilization / Activated NTRK2 signals through RAS / Interleukin receptor SHC signaling / SHC1 events in ERBB4 signaling / RHO GTPases Activate WASPs and WAVEs / GAB1 signalosome / Signal attenuation / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Schwann cell development / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / ephrin receptor binding / Signaling by CSF3 (G-CSF) / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / FRS-mediated FGFR1 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / Signaling by FGFR2 in disease / phosphotyrosine residue binding / myelination / GRB2 events in EGFR signaling / Signaling by FLT3 fusion proteins / SHC1 events in EGFR signaling / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / FCERI mediated Ca+2 mobilization / NCAM signaling for neurite out-growth / Downstream signal transduction / GRB2 events in ERBB2 signaling / insulin-like growth factor receptor signaling pathway / Insulin receptor signalling cascade / SHC1 events in ERBB2 signaling / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / T cell activation / InlB-mediated entry of Listeria monocytogenes into host cell / cellular response to ionizing radiation / B cell receptor signaling pathway / FCGR3A-mediated phagocytosis / FCERI mediated MAPK activation / Regulation of signaling by CBL / Negative regulation of FGFR3 signaling / Negative regulation of FGFR2 signaling / Negative regulation of FGFR4 signaling 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / 分子置換 / 解像度: 2.02 Å | ||||||
データ登録者 | Clements, J.H. | ||||||
引用 | ジャーナル: J.Am.Chem.Soc. / 年: 2009タイトル: Thermodynamic and Structural Effects of Conformational Constraints in Protein-Ligand Interactions. Entropic Paradoxy Associated with Ligand Preorganization. 著者: Delorbe, J.E. / Clements, J.H. / Teresk, M.G. / Benfield, A.P. / Plake, H.R. / Millspaugh, L.E. / Martin, S.F. #1: ジャーナル: Angew.Chem.Int.Ed.Engl. / 年: 2006タイトル: Ligand Preorganization May Be Accompanied by Entropic Penalties in Protein-Ligand Interactions 著者: Benfield, A.P. / Teresk, M.G. / Plake, H.R. / DeLorbe, J.E. / Millspaugh, L.E. / Martin, S.F. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 3imj.cif.gz | 61.8 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb3imj.ent.gz | 44.1 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 3imj.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 3imj_validation.pdf.gz | 1 MB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 3imj_full_validation.pdf.gz | 1 MB | 表示 | |
| XML形式データ | 3imj_validation.xml.gz | 12.4 KB | 表示 | |
| CIF形式データ | 3imj_validation.cif.gz | 17 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/im/3imj ftp://data.pdbj.org/pub/pdb/validation_reports/im/3imj | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 2 | ![]()
| ||||||||
| 3 |
| ||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 13758.543 Da / 分子数: 2 / 断片: SH2 domain / 由来タイプ: 組換発現 詳細: residues 53-163 were expressed in addition to a C-terminal 6-his tag 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: GRB2, ASH / プラスミド: pQE-60 / 発現宿主: ![]() #2: 化合物 | #3: 水 | ChemComp-HOH / | |
|---|
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.02 Å3/Da / 溶媒含有率: 39.17 % |
|---|---|
| 結晶化 | 温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 4.6 詳細: Ligand in lyophilized powder form was dissolved in a 11.2 mg/mL solution of Grb2 SH2 in water such to give a protein/ligand molar ratio of 2:1. 4 uL of this solution was mixed with 3 uL of 0. ...詳細: Ligand in lyophilized powder form was dissolved in a 11.2 mg/mL solution of Grb2 SH2 in water such to give a protein/ligand molar ratio of 2:1. 4 uL of this solution was mixed with 3 uL of 0.2 M ammonium acetate, 0.1 M sodium acetate, 30% v/v PEG MW4000, pH 4.6 to create the hanging drop, which yielded crystals of the protein-ligand complex in the presence of the above-mentioned solution after four weeks at room temperature., VAPOR DIFFUSION, HANGING DROP, temperature 298K |
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: 回転陽極 / タイプ: RIGAKU RU200 / 波長: 1.5418 Å |
| 検出器 | タイプ: RIGAKU RAXIS IV++ / 検出器: IMAGE PLATE / 日付: 2006年10月1日 |
| 放射 | モノクロメーター: blue max-flux confocal / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1.5418 Å / 相対比: 1 |
| 反射 | 解像度: 2.02→50 Å / Num. all: 14334 / Num. obs: 13832 / % possible obs: 96.5 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 2.1 % / Rmerge(I) obs: 0.047 / Χ2: 1.606 / Net I/σ(I): 16.7 |
| 反射 シェル | 解像度: 2.02→2.09 Å / 冗長度: 1.7 % / Rmerge(I) obs: 0.265 / Num. unique all: 1220 / Χ2: 1.553 / % possible all: 84.7 |
-位相決定
| 位相決定 | 手法: 分子置換 |
|---|
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換開始モデル: pdb entry 2HUW 解像度: 2.02→50 Å / Occupancy max: 1 / Occupancy min: 0.5 / 交差検証法: THROUGHOUT / σ(F): 0 / σ(I): 0 / 立体化学のターゲット値: Engh & Huber
| ||||||||||||||||||||||||||||
| 溶媒の処理 | Bsol: 31.59 Å2 | ||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso max: 55.85 Å2 / Biso mean: 26.942 Å2 / Biso min: 13.47 Å2
| ||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 2.02→50 Å
| ||||||||||||||||||||||||||||
| 拘束条件 |
| ||||||||||||||||||||||||||||
| Xplor file |
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
引用















PDBj





























